ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998

DCCP Board Gives Concept Approval to Noncompeting Contracts

June 17, 1983

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003

Cancer Advocates Ask House By Byspass Budget; NCCR’s Day Calls For $380 Mil. Minimum Increase

March 12, 1993